Pattern of IGF-1 variants' expression in human cancer cell lines using a novel q-RT-PCR approach

Anticancer Res. 2015 Jan;35(1):107-15.

Abstract

Background/aim: Although insulin-like growth factor-1 (IGF-1) is well-implicated in cancer biology, the potential roles of IGF-1 variants in different types of cancer are largely unknown. The aim of the present study was to in vitro characterize several human cancers for their IGF-1 variant expression patterns.

Materials and methods: Using a novel quantitative real-time polymerase chain reaction (qRT-PCR) assay, twelve human cancer cell lines were investigated for their endogenous expression levels of IGF-1 variants, including classes. Additionally, the hormonal regulation of IGF-1 transcripts was investigated in PC3 cells.

Results: IGF-1Ea and Eb were found at higher levels in KLE and MEL28 cells, respectively. MCF7 had the lowest expression of Ec peptide and, along with MB231, lacked IGF-1Eb. In most cases, class 1 proved as the predominant origin. Estradiol (E2) or dexamethasone (Dexa) significantly modulated IGF-1Ea and IGF-1Eb and down-regulated the Ec peptide in PC3.

Conclusion: Our results contribute to the notion of distinct roles of IGF-1 isoforms in human cancer depending on the type of malignancy.

Keywords: Ec peptide; IGF-1 classes; IGF-1 isoforms; IGF-1Ea; IGF-1Eb; cancer cell lines.

MeSH terms

  • Dexamethasone / pharmacology
  • Estradiol / physiology
  • Gene Expression
  • Human Growth Hormone / physiology
  • Humans
  • Insulin-Like Growth Factor I / genetics
  • Insulin-Like Growth Factor I / metabolism*
  • MCF-7 Cells
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • IGF1 protein, human
  • Protein Isoforms
  • Human Growth Hormone
  • Estradiol
  • Insulin-Like Growth Factor I
  • Dexamethasone